BiondVax Pharma (BVXV) Reports Q2 Loss of NIS0.05/Share

August 18, 2016 4:21 PM EDT
Get Alerts BVXV Hot Sheet
Trade BVXV Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

BiondVax Pharma (NASDAQ: BVXV) reported Q2 EPS of (NIS0.05), versus (NIS0.02) reported last year.

For earnings history and earnings-related data on BiondVax Pharma (BVXV) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment